The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
Point-of-care testing (POCT) for sexually transmitted infections offers rapid, decentralised diagnostics that inform clinical decisions within a single visit. Traditionally, laboratory-based nucleic ...
LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...
Salvatore Viscomi MD, co-founder of Carna Health is an entrepreneur with a passion for digital health and remote patient monitoring. The Covid-19 pandemic taught us that providing care outside of ...
The company’s focus on high accuracy POCT testing reagents aligns precisely with this demand, integrating robust quality control, innovative biochemistry, and user-centered design. Moreover, the ...
Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.
Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...
This will be driven by increasing demand for quick testing. The global point-of-care testing (POCT) market is projected to ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, registering a CAGR of 7.5% ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ — Ningbo Qinmeng Maternal and Child Products Co., Ltd., a subsidiary of Ningbo Ciliang Import and ...